When we last tucked into the insolvency proceedings involving Spartan Bioscience, the Ottawa DNA-testing firm was trying to finalize a restructuring — one that offered a glimmer of hope for 140-plus suppliers and more than 300 private investors. That optimism is fading. Read More
Source: Visit the Ottawa Citizen for more!